Leucine influx into six brain regions was de termined in anesthetized rats with the in situ brain per fusion technique using either saline or plasma perfusate.
port (Takasato et aI., [984) . First, the perfusion technique is 100 times more sensitive than the BU[ technique for the measurement of cerebrovascular permeability. Second, the rat� 01' regional cerebral perfusion is measured directly during perfusion, whereas the cerebral flow rate of the B UI intraca rotid bolus has never been determined experimen tally. Third, with the perfusion technique, there is negligible mixing of perfusate with blood before the perfusion fluid reaches the brain capillaries (Taka sato et aI., [984) . In contrast, the assumption that the B U [ intracarotid bolus does not mix with blood before reaching the capillaries has never been ver ified experimentally (Fenstermacher et aI., 198 I) .
Minimal mixing is important, owing to the sensi tivity of cerebrovascular amino acid transport to competition effects (Rapoport, [976; Pard ridge . 1977a) . Fourth, the perfusion technique, unlike the intravenous injection method, allows virtually ab solute control of solute concentrations in brain cap illaries. And last, the perfusion method, unlike the intravenous injection method, is not subject to er-rors in the measurement of cerebrovascular trans port due to radiotracer metabolism by tissues other than the brain (Takasato et aI., 1984) .
Because the perfusion method overcomes several problems that plagued previous techniques, we used it to characterize the transport of one LNAA, leucine, across the blood-brain barrier. We mea sured, for the first time, the concentration depen dence and stereospecificity of leucine influx into six brain regions during perfusion with physiological saline. Three models were tested to determine the best model of cerebrovascular leucine transport.
Then, the data were fitted using weighted nonlinear regression to the transport model with a saturable and a nonsaturable component to obtain new esti mates of the kinetic constants V max ' Km, and Kd• In addition, we determined leucine influx during plasma perfusion and calculated the apparent Km for leucine influx from rat plasma. Preliminary re ports of part of this work have been published (Ta kasato et aI., 1983; Smith et aI., 1984) .
METHODS

Surgical procedure
Male Osborne-Mendel rats. weighing 250-350 g. were anesthetized with sodium pentobarbital (SO mg kg-I i.p.).
A polyethylene catheter filled with heparinized saline was inserted into the right external carotid artery. 4-5 mm above the bifurcation of the common carotid artery. In addition. the right pterygopalatine artery was ligated. the right occipital and thyroid arteries were coagulated and cut, and the right common carotid artery was prepared for ligation by encircling the artery with surgical thread. Blood flow through the common carotid artery was never interrupted during the surgical procedure. Following sur gery. rat rectal temperature was maintained at 37°C by a heat lamp that was connected to a feedback device (YSI Indicating Controller. Yellow Springs. OR. U.S.A.).
Perfusion with physiological saline
A diagram of the cerebral hemisphere perfusion system is shown in Fig. 1 . In the first set of experiments, to measure L-Ieucine influx across the cerebral endothe lium, the cannula to the right external carotid artery was connected to a syringe containing 0.3 J.LCi ml-I L [14C]leucine, 1.0 J.LCi ml-I [3HJinulin, and 0-20 J.Lmol ml-I L-leucine (Sigma Chemical Co., St. Louis. MO. U.S.A.) dissolved in HCO,-buffered physiological saline (in J.Lmol ml-I: 142 NaCI, 2 8 NaHC0 3 , 4.2 KH2P0 4 , 1.7 CaS0 4 , 1.0 MgS0 4 . and 6 dextrose). The perfusion fluid was filtered, oxygenated with 95% air:5% CO" and warmed to 37°C. The pH and Peo2 of the solutio n were 7.38 ± 0.03 (SEM) and 37 ± 2 mm Hg. respectively. In the second set of experiments. to determine regional ce rebral perfusion fluid flow, [14CJdiazepam (0.3 J.Lmol ml-I) was added to the physiological saline in place of [14CJleucine, whereas in the third set of experiments, the stereospecificity of leucine transport was determined by perfusion of D-fl4C]leucine and L-eHJleucine. Because D leucine was used in only one series of experiments, L- Takasato et aI., 1984, with permission.) leucine is referred to as "'leucine" in this article, and the difference between the 0-and L-stereoisomers is noted only when appropriate.
One second prior to perfusion, the right common ca rotid artery was ligated. Then, perfusion fluid was infused into the external carotid artery at 8.3 x 10-2 ml S-I with an infusion pump (Harvard Apparatus, South Natick, MA. U.S.A.) at a measured carotid artery pressure of 120-140 mm Hg. At this infusion rate, erythrocytes were not observed with a dissecting microscope (x 40) in the cortical arteries of the right cerebral hemisphere, after a 0.3-to 0.5-cm" portion of the skull above the right hemi sphere had been removed with a dental drill. Animals were decapitated after 10-25 s of brain per fusion. The brain was removed from the skull and placed on an ice-chilled filter paper moistened with 0.9% NaCI. After the arachnoid membrane and meningeal vessels were removed, six brain regions were dissected from the right cerebral hemisphere and placed in tared vials that were reweighed. In addition, a 20-J.LI aliquot of perfusion fluid was transferred to a scintillation vial. Samples were digested overnight at 50°C in 1 ml of Protosol (New En gland Nuclear. Boston, MA. U.S.A.). Ten milliliters of Ready Solv MP (Beckman, Fullerton. CA. U.S.A.) was added to each vial, following which 3H and 14C radioac tivities were determined by liquid scintillation counting.
Perfusion with plasma
In the fourth set of experiments, leucine influx was measured during perfusion of the right cerebral hemi sphere with plasma. On the day of the experiment, whole blood was collected at 09:00-10:00 from the femoral ar tery of heparinized donor rats (100 IU sodium heparin i.v.). After centrifugation, the plasma was removed, fil tered, oxygenated with 95% O2: 5% CO2, and warmed to 37°C. L-[14CJLeucine and eHJinulin were added to the plasma to obtain the same concentrations as used in the saline perfusion experiments. The plasma solution was infused into the external carotid artery at 8.3 x 10-2 ml s -I for 25 s, after which the rat was decapitated. The brain was removed and prepared for scintillation counting. along with a sample of plasma perfusion fluid. as described above. A second sample of plasma was stored at -20°C until amino acid analysis. The HPLC method for separation of large neutral amino acids in plasma is a modification of a previously reported procedure (Fern strom and Fernstrom, 1981 ) that requires only one run with a three pump system. See the text for description of the buffers.
Plasma amino acid concentration
Plasma concentrations of 12 amino acids were deter mined by a previously reported HPLC procedure (Fern strom and Fernstrom, 1981) (Fernstrom and Fernstrom, 1981) , and separated using the conditions listed in Ta ble 1. Flow was started at 1 and stopped at 60 min, and all changes in flow or mobile phase during the run were linear. Postcolumn fluorimetric detection was obtained with a Waters model 420 AC fluorescence detector with the excitation wavelength set at 338 nm and emission wavelength at 425 nm. (Zweig and Sherma, 1972) . [3HjInulin was purified prior to usc with gel chromatography on Sephadex G-25 (Cohen, 1969) .
Radiochemicals
Kinetic analysis
In each experiment, perfusion time was limited to re strict the accumulation of tracer in the brain and thus minimize back-diffusion. Then. brain uptake follows uni directional kinetics and can be described as
where C Sr is the parenchymal brain concentration of tracer ( dpm g-f), C;r is the tracer concentration in per fusion fluid ( dpm ml-f). and t is the net perfusion time ( s) (Takasato et al.. 1984) . In Eq. I, k is a transfer coef ficient defined as
where F is the regional cerebral perfusion fluid flow ( ml S-I g-I) and PA is the capillary permeability (cm S-I) multiplied by the capillary surface area (cm 2 g-I).
Regional cerebral perfusion fluid flow was calculated from the parenchymal brain concentration of [f4Cjdiazepam after 10 s of perfusion with HC0 3 -buffered saline. [14CjDiazepam can be used to measure flow be cause the cerebrovascular P A to [14Cjdiazepam is much greater than F , and thus F ( 1e-PA1F) � F ( Takasato et aI., 1984) . Furthermore, [14Cjdiazepam binding in the brain minimizes hack-diffusion from brain into the cap illary lumen ( Mohler and Okada. 1977) . With these con ditions, Eq. 1 can be integrated from the time perfusion fluid enters the cerebral capillaries (t = 0) after starting the perfusion pump to the time of decapitation (n to give (Takasato et al.. 1984) .
The cerebrovascular PA for 14C_ or 3H-labeled leucine was determined from the parenchymal brain concentra tion of radiotracer after 10-25 s of perfusion. With mea sured F during perfusion. Eq. 1 can be integrated and rearranged to give r C* (Tl ] PA= -Fln 1 _ _ b_ r _ FTC;r (4) C/;/n was calculated by subtracting intravascular 14C_ tracer, equal to the product of regional intravascular volume (ml g-I) and perfusion fluid tracer concentration (dpm ml-I), from the total regional brain 14C content. The brain intravascular volume was determined with [,Hlinulin, which does not measurably cross the blood-brain barrier in 60 s. The intravascular volume was ex pressed as a eH]inulin space ( %), which equaled 100 x ( dpm g brain-I) 7 ( dpm ml perfusion fluid-I). In all ex periments, 5 s was subtracted from the total perfusion time to obtain T, the time that perfusate was actually within cerebral blood vessels ( Takasato et aI., 1984) . Be cause brain specific gravity equals 1.04 ( 1 ml = 1 g), PA products ( ml s -I g-I) are in units of s -I (Rapoport et aI., 1979).
Unidirectional leucine influx (lin; !Lmol s -I g -I) into the brain is defined as the product of cerebrovascular P A and mean capillary concentration (C e ap; !LmOI ml-I) ( Gjedde, 1983) . However, with the perfusion technique, regional F was two to three times greater than the highest measured PA, and thus Ceap = kC pf /PA == C pf ( Gjedde, 1983) . Thus, for these data, the expression for lin could be simplified to
Three models of leucine transport across cerebral cap illaries were examined. In the first, the concentration de pendence of leucine influx was described by the Mi chaelis-Menten equation, where V m ax is the maximal in flux rate and Km the half-saturation concentration of leucine:
Because leucine has been shown to cross simple lipid membranes by passive diffusion (Klein et aI., 1971 ), a second model was tested that contained a nonsaturable component, where K d is the constant of nonsaturable dif fusion, as well as a saturable Michaelis-Menten compo nent:
The third model consisted of two saturable components:
Because PA = li/ Cpf (Eq. 5). dividing Eqs. 6. 7, and 8 by C pf gives
To obtain best-fit values for the model parameters (V ma x ' K m, K d), Eqs. 9-11 were fitted by weighted non linear least squares to the PA data for [14Clleucine. Sim ilarly, Eq. 7 was fitted to the leucine influx data. Influx was calculated as lin = kCp f = [Cli/I)/C* f 1]C pf ( Gjedde, 1983) . The nonlinear least-squares anafyses were per formed on a DEC-lO computer with the MLAB program, which is based on the Marquardt-Levenberg curve-fitting algorithm ( Marquardt, 1963) .
Weighting factors were taken as the inverse square of the SD of leucine influx or of PA. Because five or more replicates are necessary to obtain a good experimental estimate of the SD (Atkins and Nimmo, 1980) , the SD at each perfusate concentration was calculated as follows from the magnitude of PA or lin' For the simplest weighting function, the SD was taken as proportional to the PA or lin value. To more accurately describe the re lation between the SD and the mean PA or lin value, the following equations were fitted by linear least squares to the PA or lin data, where a, b, d, f, and g are constants and X is the mean regional P A or lin at a specific perfusate leucine concentration:
Thus, weighted fits of Eqs. 7 and 10 were obtained using three weighting functions (WI):
2f, and X = (X-2g I 0g x). For comparison, unweighted fits of Eqs. 7
and 10 were obtained with WT = 1.
Nonlinear regression analysis gives SEM values for
V m ax' Km, and Kd that are only approximations and should not be used in formal statistical tests (Draper and Smith, 1981) . However, valid estimates of error can be obtained from replicate measurements of the parameters using nonlinear regression on separate sets of data. Therefore, in each brain region, the 27 observations were divided arbitrarily into three sets such that each curve had 1 ob servation at each of the nine concentrations. Best-fit pa rameters were obtained from a weighted nonlinear regres sion analysis of each data set, and the means and SEM were calculated for n = 3. Leucine influx during plasma perfusion is given as fol lows. assuming competitive inhibition of saturable leu cine transport by other plasma LNAAs:
In Eq. 17, Km(app) is the apparent Km for leucine trans port from plasma. which is defined as ( 18) where Cp t i is the plasma perfusate concentration of each competing LNAA and Km i is the corresponding Km for the LNAA (Pardridge. 1983 ).
Statistical analysis
A two-tailed Student's t test was used for the compar ison of two means. When more than two means were compared. one-way analysis of variance and the Bonfer roni multiple-comparison test were utilized to compare the individual means (Miller, 1966) . Bartlett ' s test was utilized to determine homogeneity of variance (Miller. 1966) . The tests for goodness of fit, such as the F test of the residual mean square, the signs run test, and the Rankit plot, were performed as described by Atkins (1976) and Draper and Smith (1981) . Statistical signifi cance for all tests was taken as p < 0.05. Means:':: SEM are given routinely unless otherwise noted. 
RESULTS
Cerebral perfusion flow and intravascular volume
Cerebrovascular leucine transport during
HCOrbuffered saline perfusion
Perfusion time, T, was restricted in all experi ments, so that Cb/C � f "-S 0. 2 and thus back-diffusion of 14 C-tracer from brain was negligible. While the contribution of parenchymal 14 C-tracer to total brain [ 14 C]leucine content fell from >99 to 20% as C p f was elevated to 20 /-Lmol ml-I , the use of Leucine transport across the blood-brain barrier was moderately stereospecific. The mean regional PA ratio ofL-to D-isomers ranged from 2.S7 ± 0.08 (n = 3) in the caudate nucleus to 2. 79 ± 0.02 in the hippocampus, when the brain was perfused with physiological saline containing tracer concentra tions of both stereoisomers. Several tests were used to evaluate goodness of fit, as suggested by Atkins (197 6). For each model, calculated kinetic parameters were significantly greater than zero, and convergence to a regression solution was reached in only two to four iterations (Atkins, 1976) . However, the residual mean square of Eq. 9 was reduced significantly, as determined with an F test, by adding a non saturable component to the model, and a further reduction was obtained by using a model with two saturable components ( 13. 3 ± 0.7 12. 8 ± 0.5 11.9 ± 0.7 8. 7 ± 0.6" 6. 5 ± 0.4" 8. 8 ± 0,6" Intravascular volume (%)
Calculation of best-fit kinetic parameters
1. 16 ± 0.07 1. 11 ± 0.06 1. 04 ± 0.07 0.91 ± 0.05" 0.82 ± 0.05" 0.93 ± 0.05"
Values are means ± SEM. For flow values. n 5; for intrav ascular volume values. n = 27 . Infusion rate was 8. 3 x 10-' ml s -I. Cerebral perfu sion fluid flow was calculated from th e brain uptak e of [14Cjdiazepam during 10 s of HCOl-buffered sali ne perfusion.
" Differs significa n tly from mean valu e for parietal cortex, by Bonfer roni t statistics.
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12. 8 ± 1. 0 13. 2 ± 0.6" 13. 6 ± 0. 1" 11. 4 ± 0.5" 12. 1 ± 0. 6" 11. 9 ± 0. 8" 103 ± 5(/ 54. 7. 38 ± 0.24" 7. 36 ± 0. 23" 8. 29 ± 0. 20" 5. 93 ± 0.02" 6. 51 ± 0.07" 7. 24 ± 0. 26" 5. 0 2. 93 ± 0.24" 2. 95 ± 0. 14" 3.87 ± 0.19" 2. 73 ± 0.12" 3. 17 ± 0.30" 3. 40 ± 0.13" 10. 0
1. 82 ± 0.13" 1. 86 ± 0. 13 2. 09 ± 0. 10" 1. 50 ± 0.27" 1.91 ± 0.21 1. 98 ± 0. 17" 20. 0 0.83 ± 0. 15" 1. 14 ± 0.15 1. 01 ± 0.14" 0.80 ± 0.10 0.64 ± 0.10" 0.91 ± 0. 11" Cap illary permeability-surface area product (PA) values are means ± SEM expressed as s -I x 104 for n = 3 animals.
a Differs significantly (p < 0.(5) from regional mean PA for [1 4CJleucine at th e adj acent lower concentration, by Bonferroni t statistics.
residuals from the fits of Eqs. 10 and II appeared normally distributed and randomly ordered (Draper and Smith, 1981) . Lastly, the average absolute de viation of mean experimental PA from predicted P A was 22% for the fit of Eq. 9, which is approximately two times the mean coeffi ci ent of variation of PA, 9 ± 2% (n = 9). For comparison, the average ab- Inset: Pe rfusate concentration range from 0 to 1 f1mol ml '. Each point represents a mean for three animals. The curve is the best fit of Eq. 10 to the data, using weighted nonlinear regression analysis, where V max = 10. 67 ± 0.21 x 10 4 f1mol S-1 g-1 , Km = 0. 0257 ± 0.0009 f1mOI ml " and Kd = 0. 957 ± 0. 067 x 10-4 s-1 .
solute deviation was 10% for Eq. 10 and only 6% for Eq. II. Thus, the fit of the si ngle saturable com ponent (Eq. 9) to the data was not adequate, as shown by fo ur of the six tests. In contrast, both Eqs. 10 and II were adequate models fo r the data, though Eq. 11 provided a slightly better fit than Eq. 10. Equation 10, representing the model with a sat urable and a nonsaturable component, was chosen to fit the data to provide the simplest model of amino acid transport across the blood-brain bar rier. The line in Fig. 2 is the best fit of Eq. 10 to the PA data. The best-fit line for total unidirectional influx as well as the dashed lines for the saturable and nonsaturable components is shown in Fig. 3 . Me an regional values for Vmax' Km, and Kd are listed in Ta ble 5. The means and st andard errors were obtained from replicate measurements of the parameters , using weighted nonlinear regression on three separate sets of data (see Me thods). Although there were no significant regional differences in Km or Kd, Vmax was si gnificantly greater in parietal lobe th an in hippocampus, ca udate nucleus, or thalamus hypothalamus. Lastly, the use of calculated Ccap ' obtained as kC p �PA, instead of C p f did not signifi cantly alter the best-fit values for the kinetic param et ers (Gjedde, 1983) .
Effect of weighting on calculated transport parameters
We ig hted le as t-squares analysis was utilized be cau se there was significant inhomogeneity of vari ance for both PA and fin (B artlett's test; p < 0. 05). Perfusate concentration range from 0 to 0. 5 fJ.mOI ml-1. Right: Perfusate concentration range from 0 to 20 fJ.mol ml-1. Each point represents a mean ± SEM for n = 3 animals. The curves represent total, saturable, and nonsaturable influxes as pre dicted by Eq. 7, where Vmax = 10. 67 ± 0. 21 x 10-4 fJ.mol S -1 g-l, Km = 0.0257 ± 0.0009 fJ.mol ml-1, and Kd = 0. 957 ± 0.067 x 10-4 S·-I . P A and mean regional PA, as well as the SD of l in and mean regional l in' More than a 100-fold range was observed in the SD values of both P A and l in '
The line in Fig. 4 (l eft) is the least-squares fit of Eq. 13 to the SDpA data, where d = -0. 147 ± 0.448, f = 2. 04 ± 0.34, and g = 0. 226 ± 0. 062 (r2 = 0. 841). Similarly, the line in Fig. 4 (right) is the best fit of Eq. 13 to the SDJ in data, where d = 9. 03 ± 2.72, f = 6.79 ± 1. 55, and g = 0. 786 ± 0. 214 (r2 = 0.708). Even though the goodness of fit of Eq. 12 to the SD data was significantly less than that of Eq. 13, Eq. 12 was used for comparison as an al ternative model to fit the SD data. The constants fo r the least-squares fit of Eq. 12 to the SDpA data were a = -1.69 ± 0. 16 and h = 0.799 ± 0. 056 (r2 = 0.799), whereas the constants for the fit to the SDJ in data were a = -0. 904 ± 0. 362 and b = 1. 08 ± 0. 11 (r2 = 0. 630).
Weighting factors were calculated for the PA and the lin data using three weighting fu nctions: WT = d'X-f'(X'), which best reflects the error structure of the data (see Fig. 4 ), and WT = X-2 and WT = a ' X-h ' , which only approximate the data error structure . In addition, a fo urth weighting fu nction, WT = 1, is assumed in unweighted least-squares analysis. Figure 5 illustrates the effe ct of the weighting fu nctions on the calculated parameters V max' Km, and Kd from the best fi ts of Eqs. 7 and 10. There were no significant weighting fu nction differences in V max ' Km, or Kd when the parameters were cal culated using either Eq. 7 or 10 and with WT = X-2 , WT = a 'X-b ', or WT = d'X-I '(X'). In con trast, parameters obtained from least-squares fi ts of Eq s. 7 and 10 with WT = I differed by up to three fo ld from respective values obtained with WT = d'X-I ' (X').
Cerebrovascular leucine transport during plasma perfusion
The plasma concentrations of 12 neutral amino acids, which have signifi cant affinity for the LNAA transport system of the cerebrovascular endothe lium, are listed in Ta ble 6. The mean plasma leucine concentration, O. 138 /-Lmol ml -I, was only 9% of the summed concentration of the 12 amino acids.
Ta ble 7 presents mean regional values for cere brovascular PA to L-lI4C]leucine, Km(app) fo r leu cine, and leucine influx during plasma perfusion.
Owing to competing amino acids in plasma, PA to
[14C]leucine during plasma perfusion was only 25% 100 � x ..
Z
of the expected value from saline perfusion with the same leucine concentration as in plasma. The Km(app) for leucine transport from plasma was �20 times greater than the Km from saline, and was �3 times greater than the mean plasma leucine concen tration. Even though competition by other amino acids reduced the saturable component of leucine influx by 75%, the non saturable component con tributed only 5% to total influx from plasma.
DISCUSSION
This article presents a kinetic analysis of regional cerebrovascular leucine transport, as measured with the in situ brain perfusion method of Ta kasato et al. (1984) . This perfusion method has several ad vantages over previously used methods such as the BUI technique. The concentration dependence of L-Ieucine influx into the brain can be best described Relation between the SO of the capillary permeability-surface area product (PA) for L-[14Clleucine and mean regional PA (left) and between the SO of L-leucine influx and mean regional influx (right), Each point represents the regional SO for n = 3 animals. The curves are the least-squares fit of Eq. 13 to the data. .,. ",
FIG. 5. Effect of function and weighting scheme on best-fit V max (top), Km (middle), and Kd (bottom). Best-fit parameters were obtained from nonlinear regression of the permeability surface area product (PA) data using Eq. 10 (PA function) and from nonlinear regression analysis of the unidirectional leucine influx (Jin) data using Eq. 7 (flux function). Weighting factors were calculated for the PA and the Jin data using Eqs. 14 (WT = X-2), 15 (WT = a'X-b'), and 16 [WT = d'X-I'(X')].
Fo r the unweighted fits of Eqs. 7 and 10, weighting factors were constant and equaled 1 (WT = 1). See the text for de scriptions of variables. Each bar represents a mean ± SEM for three determinations with separate data. 'Differs signifi cantly from mean value from regression analysis wit h WT = d' X-I ' (X'), by Bonferroni t statistics.
10. 67 ± 0. 21 X 10-4 /-Lmol s -I g-I; Km = 0. 0257 ± 0. 0009 /-Lmol ml-I ; and Kd = 0.9 57 ± 0. 067 x 10-4 s -I . These values diffe r by three-to fo urfold from respective values with the BUI technique (Par dridge and Oldendorf, 19 75). Vmax is significantly greater in the cerebral cortical regions than in the hippocampus, caudate nucleus, or thalamus-hypo thalamus, whereas there are no regional differences in Km or Kd. Cerebrovascular le ucine transport is stereospecific with a 2. 7-fold greater Km for the D isomer than for the L-isomer. During perfu si on of the cere bral hemisphere with plasma, the apparent Km for L-Ieucine transport into parietal lobe, 0. 564 ± 0.082 /-Lmol ml-I, is 20 times the Km during saline perfusion, owing to competitive inhibition by other LNAAs in plasma. These results indicate that when the plasma concentrations of other LNAAs remain constant, le ucine influx is a li near fu nction of plasma leucine concentration over the physiological concentration range of 0. 050-0. 450 /-Lmol ml-I . However, leucine influx will be approximately con stant when plasma concentrations of all LNAAs in crease or decrease by a constant fraction. The in situ brain perfu sion technique, unlike pre vious methods to measure cerebrovascular trans port, fu lfills se veral criteria that are necessary to accurately determine the concentration dependence of unidirectional leucine influx across the blood brain barrier. First, there is virtually absolute con trol of perfusate composition with this method, and thus the leucine concentration of perfu sate can be varied from tracer levels to ?20 /-Lmol ml-1 in the presence or absence of other LNAAs. Second, re gional cerebral perfu sion fluid flow, which must be known to accurately determine PA (see Eq. 2), is measured with this technique. Third, the high rate of saline perfu sate flow, three to fo ur times greater than regional cerebral blood flow in the conscious rat, minimizes flow-related errors in the calculation of PA (Takasato et aI. , 1984) . Fourth, cerebrovas cular P A can be measured accurately with this tech nique over a 2 x 104-fold range from a minimum of 5 x 10-6 S-I. The observed range of mean PA values in the leucine experiments, 8 x 10 2 , fa lls well within the limits of the method. Furthermore, the calculation of cerebrovascular PA is based on a simple model of uptake into the CNS and the as sumption of unidirectional ki netics. Fifth, there is negligible mixing of perfu sion fluid with circulating blood before the pelfusate reaches the brain capil- laries. Mixing of perfusion fluid with circulating blood, as might occur at the circle of Willis, would alter the amino acid concentration of perfu sate be fo re the fluid reached brain capillaries. Sixth, the high flow rate minimizes the effe ct of LNAA efflux from brain on capillary amino acid concentration. The maximal contribution of efflux to mean capil lary concentration can be estimated as CefT = V maxi 2F = 0.0042 f-Lmol ml-I, which is only one-sixth the Km fo r leucine. Last, perfusion does not alter the passive permeability of the blood-brain barrier (Takasato et aI., 1984) . Thus, the in situ brain per fu sion technique is well suited to quantitatively ex amine saturable amino acid transport at the blood brain barrier.
The concentration dependence of leucine influx into the brain is described adequately by a model with a saturable and a nonsaturable component. al though a model with two saturable components gives a slightly better fit to the data. However, the model with the nonsaturable component was chosen for three reasons. First, the improvement in fit with the two-saturable component model is modest and significant in only one of the tests of goodness of fit. Second, leucine is known to cross lipid membranes by passive diffusion (Klein et aI., 1971) , and the best-fit values fo r the Kd of the dif fu sional component, 0.84-1.42 x 10-4 S-I, ap proximate the PA value, 2.5 x 10-4 s -I, predicted by the octanollwater partition coefficient for leucine and the empirical relation between the partition coefficient and PA (Yunger and Cramer, 1981; Ta kasato et aI., 1984) . And last, there is no evidence for a second saturable component in the cerebro vascular influx of isoleucine or cyc10leucine (Ta kasato et aI., 1983) . If a second saturable component existed fo r leucine, the transport system would have to be leucine specific, a possibility that was considered unlikely (C hri stensen, 1969; Kilberg, 1982) .
Best-fit values for the ki netic constants were ob tained with weighted nonlinear regressi on analysis of the data. For a model with a saturable and a non saturable component, weighted nonlinear regression is su perior to graphical methods and most nonparametric procedures fo r the determina tion of V max ' Km, and Kd (C unningham and Sarna, 1979; Atkins and Nimmo, 1980; Atkins, 1983) .
Regressi on analysis, however, requires appro priate weighting when there is inhomogeneity of variance in the data (Atkins and Nimmo, 1980; Draper and Smith, 1981) . Although nonlinear regression has been used to determine the V max and Km of cerebrovascular LNAA transport, adequate weighting of the data was not employed in these studies (Pardridge and Oldendorf, 1975; Daniel et aI., 1977; Pardridge and Mietus, 1982) , even though there is significant inhomogeneity of variance in PA, l in ' and BUI data (C unningham and Sarna, 1979 ; see also Fig. 4 ). In fac t, Pardridge (1983) claims that weighting is not required for regression analysis of PA data. Therefore, we tested fo ur dif fe rent weighting sc hemes to determine the se nsi tivity of the kinetic parameters to the weighting fu nctions.
The lack of significant weighting fu nction diffe r ences in V max ' Km, or Kd when the parameters were obtained with either Eq. 7 or 10 and with any of the three weighting schemes that reflected the relative proportionality between the SD and the mean in dicates that the best-fit values of the constants are not sensitive to the exact fo rm of the weighting fu nction or to calculation in terms of PA or lin '
However, nonlinear regression does require a weighting scheme that reflects the general relation ship between the error in the dependent variable and the magnitude of the variable, as shown by the significantly different values fo r the kinetic con stants from unweighted as opposed to weighted fits. Therefore, either Eq. 7 or 10 can be fi tted with non-linear least squares to adequately weighted lin or PA data, respectively, to obtain accurate best-fit values fo r the kinetic constants. Failure to use weighted nonlinear regression to analyze data with inhomogeneous variance will result in biased and imprecise estimates of kinetic constants.
The cerebrovascular Vmax for leucine with the brain perfusion technique is similar to the value of 11. 7 x 10-4 f.1mol s -I g-l reported by Daniel et al. (1977) with the intravenous infusion method, but is three times the value obtained with the BUI tech nique (Pardridge and Mietus, 1982; Pardridge , 1983 , 1975; Pardridge and Mietus, 1982) , the flow of the bolus may be three to four times greater than blood flow, owing to the low viscosity of the saline injectate (Takasato et aI., 1984) .
In contrast to that of Vmax' the values of Km and Kd for leucine with the BUI method are fo ur times greater than with the perfusion method. The signif icantly higher Km value with the B U I method may be due to the addition of competing amino acids to the bolus through mixing with plasma or efflux from the brain. The amount of mixing has not been de termined with the BUI method , though significant mixing probably occurs at the injection site and at the circle of Willis (Fenstermacher et aI., 1981; Ta kasato et aI., 1984) . Furthermore . LNAA efflux from brain would have a greater effect on the B U I method if the flow of the carotid bolus were less than cerebral perfusion fl uid flow.
Similar values for Km in six brain regions with the brain perfusion technique suggest that there are no regional differences in the affinity of the LN AA transport carrier at the cerebral endothelium. The greater regional V max ' as well as F and intravascular volume, values in the cerebral cortical lobes than in the other brain regions are consistent with the greater vascularity of the cortex (Craigie. 1920) , and may suggest that the number of transport carriers per square centimeter of capillary surfa ce area is the same in the six brain regions.
Perfusion with rat plasma can be utilized to de termine leucine influx under normal physiological conditions, i.e., from a perfusate that contains physiological concentrations of leucine as well as other LNAAs. Regional values for leucine influx during plasma perfusion, 2. 0-2. 5 x 10 -4 f.1mol S-I g-I , compare fa vorably with the values in unper-J Cereb Blood Flow Metabol. Vol. 5, No.2. 1985 fu sed rats, 1. 6-2. 7 x 10-4 f.1mol S-I g-I (Bodsch and Hossmann, 1982; Mans et aI., 1982) . Further more, the low PA for [14C]leucine during plasma perfusion indicates that leucine influx is not limited by flow in either the perfused or unperfused rat.
For example, with a PA of 17 x 10-4 S-l (Table 7) , a 13-fold increase in Ff rom 1. 0 x 10-2 ml S-I g -I (cerebral blood flow in the pentobarbital-anesthe tized rat) (Pardridge and Mietus, 1982) would in crease the calculated l i n by only 8%.
Leucine influx during plasma perfusion is only 25% of that predicted during saline perfusion at the same leucine concentration, owing to competition for transport by other LN AAs in the plasma (Daniel et aI., 1977; Pardridge , 1977b; Pratt , 1979) . Com petitive inhibition increases the apparent Km fo r leu cine transport during plasma perfusion by 20 times to 0. 50 f.1mol ml-I. Thus, as shown in Fig. 6 , leucine influx is a linear fu nction of plasma leucine concen tration over the normal physiological range of 0. 05-0. 45 f.1mol ml -I, when the plasma concentrations of other LNAAs remain constant. Furthermore , the saturable component of leucine influx will exceed 1/ 2 V max only when the plasma leucine concentration is >0.50 f.1mol ml-I, as occurs under pathological conditions such as maple syrup urine disease (Tanaka and Rosenberg, 1983) . Because the trans port system is 96% saturated with LNAAs at normal plasma concentrations , an increase in plasma leucine concentration and thus influx will decrease the influx of other LNAAs into the brain. Last, the nonsaturable component contributes min imally to leucine infl ux from plasma, constituting only 5% of total influx at normal plasma concentra tions, and increasing to only 16% with a lO-fold elevation of plasma leucine concentration (Fig. 6 ).
Whereas leucine influx will be a linear fu nction of plasma leucine concentration up to 0. 45 f.1mol ml-I when the plasma concentrations of other LNAAs are maintained unchanged, leucine influx should remain approximately constant when the plasma concentrations of all LN AAs increase or de crease by a constant fraction. as may occur after a high-protein meal or during fa sting (Fernstrom et al.. 1971; Glaeser et al.. 1983 ). If the plasma con centration of each LNAA changes by the same frac tion. 1\' , then leucine influx is given by Eqs. 17 and 18 as 
